A detailed history of Ikarian Capital, LLC transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 157,862 shares of ANEB stock, worth $255,736. This represents 0.05% of its overall portfolio holdings.

Number of Shares
157,862
Previous 157,862 -0.0%
Holding current value
$255,736
Previous $430,000 29.3%
% of portfolio
0.05%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$2.15 - $3.49 $3,566 - $5,789
1,659 Added 1.06%
157,862 $483,000
Q3 2022

Nov 14, 2022

SELL
$2.8 - $5.49 $69,988 - $137,228
-24,996 Reduced 13.79%
156,203 $437,000
Q1 2022

May 13, 2022

BUY
$6.0 - $7.7 $53,340 - $68,453
8,890 Added 5.16%
181,199 $1.23 Million
Q3 2021

Nov 15, 2021

SELL
$6.55 - $7.77 $16,388 - $19,440
-2,502 Reduced 1.43%
172,309 $1.16 Million
Q2 2021

Aug 16, 2021

BUY
$6.58 - $8.95 $1.15 Million - $1.56 Million
174,811 New
174,811 $1.2 Million

Others Institutions Holding ANEB

About Anebulo Pharmaceuticals, Inc.


  • Ticker ANEB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,633,200
  • Market Cap $41.5M
  • Description
  • Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...
More about ANEB
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.